EBELE MBELEDOGU: Open Payments
NPI 1689071169 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,544 in 28 payments from 6 companies in 2025. Trend: 2023 $1,355 · 2024 $858 · 2025 $1,544
Food & beverage: $1,333Education: $211
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $555 |
| Alkermes, Inc. | 8 | $459 |
| Neurocrine BioSciences, Inc. | 7 | $251 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
Products named: UZEDY, INGREZZA, LYBALVI, ARISTADA, Auvelity, COBENFY, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
